Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04866680
Status:
RECRUITING
Last Update Posted:
2024-03-05
First Post:
2021-03-09
Brief Title:
Personalized Circulating DNA Follow-up in Melanoma PERCIMEL
Sponsor:
Institut de Cancérologie de Lorraine
Organization:
Institut de Cancérologie de Lorraine
Study Overview
Official Title:
Personalized Circulating DNA Follow-up in Melanoma
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PERCIMEL
Brief Summary:
PERCIMEL is an open multicentric study The purpose of this study is to assess the interest of molecular analysis on circulating tumor DNA in the follow-up of the disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None